Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

OrthoPediatrics Affirms FY2025 Sales Guidance of $233.500M-$234.500M vs $235.476M Est

Author: Benzinga Newsdesk | October 28, 2025 03:08pm
OrthoPediatrics (NASDAQ:KIDS) affirms FY2025 sales outlook from $233.500 million-$234.500 million to $233.500 million-$234.500 million vs $235.476 million estimate.

Posted In: KIDS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist